AccelAV: Accelerometer Sensing for Micra AV Study

Sponsor
Medtronic Cardiac Rhythm and Heart Failure (Industry)
Overall Status
Completed
CT.gov ID
NCT04245345
Collaborator
(none)
157
20
1
19.1
7.9
0.4

Study Details

Study Description

Brief Summary

The purpose of the AccelAV Study is to characterize chronic AV synchrony in subjects implanted with MicraTM AV device. This study will be conducted upon market approval of the MicraTM AV Transcatheter Pacing System.

Condition or Disease Intervention/Treatment Phase
  • Device: Accelerometer Sensing for Micra AV Study
N/A

Detailed Description

The Accel AV study is a prospective, single-arm, global, multi-center clinical study to characterize the chronic AV synchrony in subjects implanted with the market released Micra AV system. The study is planned to be conducted in the US and Hong Kong. Overall, the study is expected to be conducted at approximately 20 centers.The expected total study duration is approximately 12-15 months, representing the time necessary to enroll the target sample size and to complete the 3-month follow-up visit.

Study Design

Study Type:
Interventional
Actual Enrollment :
157 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Accelerometer Sensing for Micra AV Study
Actual Study Start Date :
Jun 9, 2020
Actual Primary Completion Date :
Jan 1, 2022
Actual Study Completion Date :
Jan 10, 2022

Arms and Interventions

Arm Intervention/Treatment
Other: Single-arm

Device: Accelerometer Sensing for Micra AV Study
Characterize AV synchrony in subjects implanted with Micra AV device. The study will be conducted upon market approval of the Micra AV Transcatheter Pacing System.

Outcome Measures

Primary Outcome Measures

  1. AV synchrony percentage during rest [1-month post-implant]

    Characterize percentage of cardiac cycles during the 20-minute resting period at the 1-month follow-up visit, where a paced or sensed ventricular beat is within 300 ms following an ECG confirmed P-wave.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:

Subject will be implanted with a MicraTM (Model MC1AVR1) for an approved indication.

  • Subject has history of AV block.

  • Subject is ≥ 18 years old and as per required local law.

  • Subject (and/or witness as applicable per local regulations) provides signed and dated authorization and/or consent per institution and local requirements.

  • Subject is willing and able to comply with the protocol.

Exclusion Criteria:
  • Subject currently enrolled or planning to participate in a potentially confounding drug or device trial during the study. Co-enrollment in concurrent trials is only allowed when documented pre-approval is obtained from the Medtronic Clinical Research Specialist.

  • Subject implanted with a MicraTM (Model MC1AVR1) on a non-permanent basis (e.g. CIED infection).

  • Subject is pregnant (if required by local law, women of child-bearing potential must undergo a pregnancy test within seven days prior to MicraTM Model MC1AVR1 implant procedures).

  • Subject meets any exclusion criteria required by local law (age or other).

Contacts and Locations

Locations

Site City State Country Postal Code
1 Saint Joseph's Medical Center Stockton California United States 95204
2 Baptist Medical Center Jacksonville Jacksonville Florida United States 32207
3 Citrus Cardiology Consultants PA Leesburg Florida United States 34748
4 Emory University Hospital Atlanta Georgia United States 30322
5 Catholic Medical Center Manchester New Hampshire United States 03102
6 Northwell Health Manhasset New York United States 11030
7 NYU Langone Medical Center New York New York United States 10016
8 Duke University Nedical Center Durham North Carolina United States 27710
9 Wake Forest Baptist Medical Center Winston-Salem North Carolina United States 27157
10 University Hospitals Cleveland Medical Center Cleveland Ohio United States 44106
11 The Ohio State University Wexner Medical Center Columbus Ohio United States 43210
12 Mount Carmel Health System Columbus Ohio United States 43213
13 Oregon Health & Science University Portland Oregon United States 97239
14 Thomas Jefferson University Philadelphia Pennsylvania United States 19107
15 Centennial Heart Cardiovascular Consultants Nashville Tennessee United States 37203
16 Baylor Research Institute Plano Texas United States 75093
17 Multicare Institute for Research and Innovation Tacoma Washington United States 98405
18 University of Wisconsin (UW) Hospital and Clinics Madison Wisconsin United States 53792
19 Queen Mary Hospital Hong Kong HK Hong Kong
20 Prince of Wales Hospital Sha Tin HK Hong Kong

Sponsors and Collaborators

  • Medtronic Cardiac Rhythm and Heart Failure

Investigators

  • Study Chair: Larry Chinitz, MD, NYU Langone

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Medtronic Cardiac Rhythm and Heart Failure
ClinicalTrials.gov Identifier:
NCT04245345
Other Study ID Numbers:
  • AccelAV
First Posted:
Jan 28, 2020
Last Update Posted:
Jun 23, 2022
Last Verified:
Jun 1, 2022
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
Yes
Product Manufactured in and Exported from the U.S.:
Yes
Keywords provided by Medtronic Cardiac Rhythm and Heart Failure
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jun 23, 2022